Rivoceranib for advanced thymus cancer
Treatments studied
Part of Cancer, Immune system & allergy clinical trials.
This trial tests a drug called Rivoceranib for people with thymus cancer that has spread and continues to grow after initial treatment. The goal is to see if it can help control the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older.
- You have thymus cancer that has spread to other parts of the body.
- Your cancer has grown after at least one prior treatment.
- You are not a candidate for surgery and need more treatment.
- You have not taken a similar drug (like sunitinib or bevacizumab) before.
- You have adequate kidney, liver, and bone marrow function as shown by blood tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial tests whether combining rivoceranib with paclitaxel can shrink or control advanced metastatic gastrointestinal stromal tumor (GIST) after standard medicines have stopped working. It may help people whose GIST has progressed despite prior treatments like imatinib, sunitinib, and regorafenib.
This trial tests a new drug called ivonescimab for thymic carcinoma that has come back or isn't responding to other treatments. It aims to see if this drug can shrink the cancer and help you feel better.
This trial tests a new drug, ivonescimab, combined with chemotherapy for people with thymic cancer that has spread or come back. The goal is to see if this combination can help shrink or control the cancer.
This trial tests a combination of new drugs (SHR-1701, Rivoceranib, and possibly SHR-2554) for people with advanced stomach cancer whose disease has continued to grow after immunotherapy. It aims to find a better treatment option for those who have not had success with standard therapy.
This trial tests a new drug, sacituzumab tirumotecan, in people with advanced thymic carcinoma that has spread or cannot be removed with surgery. It is for those whose cancer has gotten worse after at least one round of platinum-based chemotherapy.
This trial tests a combination of two drugs (tivozanib and nivolumab) for people with advanced kidney cancer that is not clear cell type. It aims to see if this drug pair can shrink or slow the cancer.
Hear when a new Thymic Epithelial Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.